| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1083858723 |
| P356 | DOI | 10.1186/S12885-017-3137-4 |
| P932 | PMC publication ID | 5322605 |
| P698 | PubMed publication ID | 28228122 |
| P50 | author | Anthony Ho | Q20742599 |
| Hartmut Goldschmidt | Q23061917 | ||
| Mathias Witzens-Harig | Q45514575 | ||
| Thomas Bruckner | Q86708781 | ||
| Patrick Wuchter | Q88755174 | ||
| Jens Hillengass | Q95829739 | ||
| Gerlinde Egerer | Q114309071 | ||
| P2093 | author name string | Sandra Sauer | |
| Katharina Lisenko | |||
| Sofia Shah | |||
| Johann W Schmier | |||
| P2860 | cites work | Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity | Q26771331 |
| Salvage second hematopoietic cell transplantation in myeloma | Q30416452 | ||
| High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma | Q34195428 | ||
| International uniform response criteria for multiple myeloma. | Q34549410 | ||
| Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. | Q35288778 | ||
| Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma | Q35812033 | ||
| Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. | Q36974379 | ||
| European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma | Q37552008 | ||
| Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. | Q38209433 | ||
| Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma | Q40208242 | ||
| Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial | Q40489194 | ||
| Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma | Q40571532 | ||
| Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma. | Q41124362 | ||
| High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation. | Q43490516 | ||
| Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes. | Q43610114 | ||
| Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis | Q43758764 | ||
| Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation | Q44385832 | ||
| Single versus double autologous stem-cell transplantation for multiple myeloma. | Q44706045 | ||
| Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma | Q45836179 | ||
| Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial | Q48065378 | ||
| A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome | Q71123629 | ||
| Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies | Q71975295 | ||
| Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma | Q73740223 | ||
| Reduced charges and costs associated with outpatient autologous stem cell transplantation | Q74615284 | ||
| Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma | Q79876022 | ||
| Quality of life, quality of care, and patient satisfaction: perceptions of patients undergoing outpatient autologous stem cell transplantation | Q81296951 | ||
| Long-Term Follow-Up of Tandem Autologous Stem-Cell Transplantation in Multiple Myeloma | Q82364366 | ||
| Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation | Q84931074 | ||
| Autologous stem cell transplantation: an effective salvage therapy in multiple myeloma | Q85552314 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 151 | |
| P577 | publication date | 2017-02-22 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting | |
| P478 | volume | 17 |
| Q45968380 | Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma. |
| Q38704146 | Melphalan hydrochloride for the treatment of multiple myeloma |
| Q59339945 | Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis |
Search more.